Twitter history of @soragnilab
@twitter.soragnilab.com
This is an archive of old Twitter posts from soragnilab - some thousand of messages incoming, beware!
Always on Bluesky, find us there: https://bsky.app/profile/alice.soragnilab.com
Soragni:Lab (@alice.soragnilab.com)
Of protein aggregation, rare cancer biology, and organoid...
bsky.app
November 26, 2024 at 5:14 AM
Always on Bluesky, find us there: https://bsky.app/profile/alice.soragnilab.com
Good news/bad news day today.. Good news first! Our sarcoma organoid paper (https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(24)00296-0) is in officially out and published, and there is a very thoughtful commentary to accompany...
November 26, 2024 at 5:14 AM
Good news/bad news day today.. Good news first! Our sarcoma organoid paper (https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(24)00296-0) is in officially out and published, and there is a very thoughtful commentary to accompany...
Organoids from almost any type of carcinoma have been developed, but non-epithelial cancers lagged behind - until now!
Here is our paper developing patient-derived sarcoma organoids from 110+ samples, 20+ types of sarcomas, rare bone and soft tissue...
Here is our paper developing patient-derived sarcoma organoids from 110+ samples, 20+ types of sarcomas, rare bone and soft tissue...
November 26, 2024 at 5:14 AM
Organoids from almost any type of carcinoma have been developed, but non-epithelial cancers lagged behind - until now!
Here is our paper developing patient-derived sarcoma organoids from 110+ samples, 20+ types of sarcomas, rare bone and soft tissue...
Here is our paper developing patient-derived sarcoma organoids from 110+ samples, 20+ types of sarcomas, rare bone and soft tissue...
Go here to read how this started as a totally unrelated poster at a huge conference and turned into a whole research program 👀: https://www.linkedin.com/posts/alicesoragni_finding-new-treatments-for-genetic-tumor-predisposition-activity-7232093661532987393-PZPC
November 26, 2024 at 6:52 AM
Go here to read how this started as a totally unrelated poster at a huge conference and turned into a whole research program 👀: https://www.linkedin.com/posts/alicesoragni_finding-new-treatments-for-genetic-tumor-predisposition-activity-7232093661532987393-PZPC
Lots of good news to share on our NF1 work. Our platform to screen cutaneous neurofibroma organoids was recently published & we were awarded two grants from @ntapresearch and @GilbertFamilyFd to take these models to the next level. So proud of this...
November 26, 2024 at 5:14 AM
Lots of good news to share on our NF1 work. Our platform to screen cutaneous neurofibroma organoids was recently published & we were awarded two grants from @ntapresearch and @GilbertFamilyFd to take these models to the next level. So proud of this...
Our roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35457
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35457
November 26, 2024 at 5:14 AM
Our roadmap for the next generation of Children’s Oncology Group rhabdomyosarcoma trials
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35457
https://acsjournals.onlinelibrary.wiley.com/doi/full/10.1002/cncr.35457
✨Very happy to share that we have a new paper published this morning that expands our high throughput organoid screening platform to a type of heterogenous, benign tumors called on cutaneous neurofibromas (cNFs).
You can find it here:...
You can find it here:...
November 26, 2024 at 6:10 AM
✨Very happy to share that we have a new paper published this morning that expands our high throughput organoid screening platform to a type of heterogenous, benign tumors called on cutaneous neurofibromas (cNFs).
You can find it here:...
You can find it here:...
We have a new collaborative paper out! Tweetorial to follow, but so excited to see this follow up to one of my PhD/postdoc projects:
https://www.cell.com/cell-reports/fulltext/S2211-1247(24)00412-1
https://www.cell.com/cell-reports/fulltext/S2211-1247(24)00412-1
November 26, 2024 at 6:10 AM
We have a new collaborative paper out! Tweetorial to follow, but so excited to see this follow up to one of my PhD/postdoc projects:
https://www.cell.com/cell-reports/fulltext/S2211-1247(24)00412-1
https://www.cell.com/cell-reports/fulltext/S2211-1247(24)00412-1
It's finally organoids day at #AACR24!! Join us for the AT05 session at 12:30pm in Ballroom CD to see how we use tumor organoids for immunooncology, for rare tumors modeling and precision medicine, for undestanding tumor...
November 26, 2024 at 6:52 AM
It's finally organoids day at #AACR24!! Join us for the AT05 session at 12:30pm in Ballroom CD to see how we use tumor organoids for immunooncology, for rare tumors modeling and precision medicine, for undestanding tumor...
Love to hear about the motivation behind the seven new advances in technology sessions at #AACR24 from this year meeting co-chair, Dr. Cristina Curtis. Putting together a program for such a meeting is a behemoth challenge, congrats @cncurtis and Dr. Flaherty on an amazing job!
November 26, 2024 at 7:52 AM
Love to hear about the motivation behind the seven new advances in technology sessions at #AACR24 from this year meeting co-chair, Dr. Cristina Curtis. Putting together a program for such a meeting is a behemoth challenge, congrats @cncurtis and Dr. Flaherty on an amazing job!
We have a new lab website!! So happy that https://www.soragnilab.com/ is now live, and in time for #AACR24. I am very thankful to the entire @stellatecomms team that turned my vision into a coherent reality! Have a look around and let me know what you think
Soragni Lab - Home
The Soragni Lab at UCLA investigates protein aggregation ...
www.soragnilab.com
November 26, 2024 at 7:53 AM
We have a new lab website!! So happy that https://www.soragnilab.com/ is now live, and in time for #AACR24. I am very thankful to the entire @stellatecomms team that turned my vision into a coherent reality! Have a look around and let me know what you think
It's almost time for the annual AACR meeting and y'all know what that means.....
.......tax season is upon us!! 😆
Jokes aside, very excited for this year's meeting, lots of incredibly cool science, tons of networking. Will be sharing our work soon as well!
.......tax season is upon us!! 😆
Jokes aside, very excited for this year's meeting, lots of incredibly cool science, tons of networking. Will be sharing our work soon as well!
November 26, 2024 at 8:43 AM
It's almost time for the annual AACR meeting and y'all know what that means.....
.......tax season is upon us!! 😆
Jokes aside, very excited for this year's meeting, lots of incredibly cool science, tons of networking. Will be sharing our work soon as well!
.......tax season is upon us!! 😆
Jokes aside, very excited for this year's meeting, lots of incredibly cool science, tons of networking. Will be sharing our work soon as well!
Incredibly humbled and grateful for the C2C's team efforts in fundraising for our pediatric sarcoma research. C2C is spearheaded by a group of fantastic teen advocates, check out their fundraising page to learn more about their amazing work and motivation: https://givebutter.com/c2c
Chords2Cure 2024
Raising funds for pediatric cancer research at UCLA
givebutter.com
November 26, 2024 at 8:43 AM
Incredibly humbled and grateful for the C2C's team efforts in fundraising for our pediatric sarcoma research. C2C is spearheaded by a group of fantastic teen advocates, check out their fundraising page to learn more about their amazing work and motivation: https://givebutter.com/c2c
Celebrating a fantastic yet totally unfundable 12% today 😀😩🙃😀
November 26, 2024 at 8:43 AM
Celebrating a fantastic yet totally unfundable 12% today 😀😩🙃😀
Nice surprise to be part of this @TheScientistLLC feature on high throughput screening approaches together with @ctmurphy1!
https://www.the-scientist.com/high-throughput-screening-models-ramp-up-lead-discovery-71666
https://www.the-scientist.com/high-throughput-screening-models-ramp-up-lead-discovery-71666
High Throughput Screening Models Ramp up Lead Discovery
Fast, automated, and relevant biological tools and techno...
www.the-scientist.com
November 26, 2024 at 9:30 AM
Nice surprise to be part of this @TheScientistLLC feature on high throughput screening approaches together with @ctmurphy1!
https://www.the-scientist.com/high-throughput-screening-models-ramp-up-lead-discovery-71666
https://www.the-scientist.com/high-throughput-screening-models-ramp-up-lead-discovery-71666
Another paper using our mini-ring approach for organoid drug testing - it is never not going to be exciting to see this in the wild!
https://www.biorxiv.org/content/10.1101/2023.12.19.572069v1
https://www.biorxiv.org/content/10.1101/2023.12.19.572069v1
Neratinib Synergizes with Trastuzumab Antibody Drug Conju...
HER2 ( ERBB2 ) is a major therapeutic drug target in brea...
www.biorxiv.org
November 26, 2024 at 9:31 AM
Another paper using our mini-ring approach for organoid drug testing - it is never not going to be exciting to see this in the wild!
https://www.biorxiv.org/content/10.1101/2023.12.19.572069v1
https://www.biorxiv.org/content/10.1101/2023.12.19.572069v1
So. Many. Emails.
November 26, 2024 at 9:31 AM
So. Many. Emails.
We are re-doing our lab website and would love to hear what resonates with people the most. Any awesome lab website examples to share??
November 26, 2024 at 9:31 AM
We are re-doing our lab website and would love to hear what resonates with people the most. Any awesome lab website examples to share??
Very beautiful, exciting work from @TalyaDayton characterizing drug dependencies in neuroendocrine tumors
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00398-7
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00398-7
November 26, 2024 at 10:23 AM
Very beautiful, exciting work from @TalyaDayton characterizing drug dependencies in neuroendocrine tumors
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00398-7
https://www.cell.com/cancer-cell/fulltext/S1535-6108(23)00398-7
Seventh consecutive seminar invite sent out, accepted and scheduled. All are women. It's not that hard, is it.
November 26, 2024 at 10:23 AM
Seventh consecutive seminar invite sent out, accepted and scheduled. All are women. It's not that hard, is it.
In my experience there are two types of scientists. Those that freely present unpublished data with little to no reservation and those who don’t. Mandated policies rarely make a difference as the divide is large.
Are Gordon Research Conferences still following Fight Club rules?
November 26, 2024 at 11:33 AM
In my experience there are two types of scientists. Those that freely present unpublished data with little to no reservation and those who don’t. Mandated policies rarely make a difference as the divide is large.
Are Gordon Research Conferences still following Fight Club rules?
November 26, 2024 at 10:23 AM
Are Gordon Research Conferences still following Fight Club rules?
Have talked about all the open data and code, now time for the science! Why did we decide to develop a new, 3D organoid drug screening platform? To chase one of the biggest issues behind treatment failure and tumor recurrence: those few drug resistant cells surviving treatment 🧵
We have a new paper out on our label-free, single organoid resolution imaging platform! All of our data and code? Also publicly available! 🧵
📰 https://www.nature.com/articles/s41467-023-38832-8
📰 https://www.nature.com/articles/s41467-023-38832-8
Drug screening at single-organoid resolution via bioprint...
Traditional 2D cell culture platforms do not accurately r...
www.nature.com
November 26, 2024 at 11:33 AM
Have talked about all the open data and code, now time for the science! Why did we decide to develop a new, 3D organoid drug screening platform? To chase one of the biggest issues behind treatment failure and tumor recurrence: those few drug resistant cells surviving treatment 🧵